About Joel Dudley
Form D filings for Syrna Therapeutics in 2023 list Joel Dudley as director.
Joel Dudley first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Joel Dudley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joel Dudley works with at each company, as listed on that company's latest Form D.
Syrna Therapeutics, Inc. · Form D, Aug 10, 2023